Barringer Technologies Inc. Receives FAA Contract for Up to $15 Million; Company Also Anticipates Record Second Quarter Revenues and Earnings.

Business Editors

WARREN, N.J.--(BUSINESS WIRE)--July 21, 2000

Barringer Technologies Inc. (Nasdaq: BARR) announced today that it has received a significant new order from the Federal Aviation Administration for additional IONSCAN(r) trace detectors. Together with associated supplies, the new FAA contract has a value of approximately $10 million. The FAA also has the right to obtain certain services from Barringer over a three- year period which, if fully utilized, would add an additional $5 million to the value of the contract. While equipment deliveries are expected to commence during the third quarter of 2000, the Company expects that the bulk of the revenues from the sale of this equipment to the FAA will be recognized in the fourth quarter of 2000 and into the first half of 2001.

Mr. Kenneth Wood, President of Barringer Technologies, indicated, "As the leading supplier to the FAA for trace detection equipment, we are very pleased with this award. To date, Barringer has delivered and installed in excess of 425 of its IONSCAN(r) detectors at major airports throughout the country. Our IONSCAN(r) detectors have now examined over 40 million individual items at U.S. airports."

Separately, Mr. Stanley Binder, Chairman and Chief Executive Officer said, "Based on our initial financial review for the quarter ended June 30, 2000, we anticipate reporting record revenue and earnings. We expect to report revenue of approximately $8.5 million, and earnings per diluted share of between $0.21 and $0.24, significantly above last year's revenue of $5.5 million and earnings per share of $0.12. Additionally, we expect full-year earnings per diluted share to range between $0.45 and $0.50. The Company's growth is the result of several factors, most notably the recent shipment of the majority of an order to the Israeli government.

The Company's momentum continues to build as we anticipate marketing our technology for the detection of food pathogens and chemical warfare."

Headquartered in Warren, New Jersey, Barringer Technologies Inc. is principally engaged in developing, manufacturing, and marketing of high technology products for drug, explosive and chemical detection and other security and industrial applications. The Sabre 2000(r) and the IONSCAN(r) are the Company's proprietary trace particle drug and explosive detection units.

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. When used in this press release, the words "estimate," "project," "believe," "anticipate," "intend," "expect," "plan," "predict," "may," "should," "will," the negative thereof and similar expressions are intended to identify forward-looking statements. Such statements reflect the current views of the Company with respect to future events based on currently available information and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements.

Factors that could cause actual results to differ materially from the Company's expectations include, but are not limited to, the following: general economic and political conditions, conditions in the markets for the Company's products, and risks associated with new product introductions such as: manufacturing delays, unexpected manufacturing costs, increased selling costs, failure to properly estimate demand, delays in market acceptance, increased warranty expenses, delays in the development of new applications, risks related to the Company's ability to successfully commercialize new applications and the timing thereof. Other factors may be described from time to time in the Company's public filings with the Securities and Exchange Commission, news releases and other communications. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to release publicly any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.